Thrombophilia and immunological disorders in pregnancies as risk factors for small for gestational age infants

Authors: Verspyck, Eric1; Le Cam-Duchez, Véronique2; Goffinet, François3; Tron, François4; Marpeau, Loïc1; Borg, Jeanne Yvonne2

Source: BJOG: An International Journal of Obstetrics & Gynaecology, Volume 109, Number 1, January 2002 , pp. 28-33(6)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Abstract:

Objectives

To determine if inherited thrombophilia and immunological disorders represent risk factors for small for gestational age infants, and to assess their relationship with neonatal status. Design

Case-control study. Population

Ninety-seven consecutive women who had pregnancies complicated by unexplained small for gestational age infants, defined as a birthweight below the third centile and 97 women as controls who delivered infants with a birthweight ≥10th centile. Methods

Patients were included in the immediate postpartum period and tested for antithrombin III, protein C, protein S, anticardiolipin and antinuclear antibodies, lupus anticoagulant, Factor V Leiden mutation, prothrombin 20210A mutation, and methylenetetrahydrofolate reductase (MTHFR) polymorphism. Women with small for gestational age infants were then divided into subgroups depending on haemostatic and immunologic status in order to compare neonatal events. Results

Frequencies for anticardiolipin and antinuclear antibodies were higher in women with small for gestational age infants compared with controls ( P= 0.02 and P= 0.004, respectively ), and overall prevalence of inherited thrombophilia were comparable in cases and controls (19.6% and 18.6%, respectively). The subgroups of patients with small for gestational age infants were women with only one inherited thrombophilia ( n= 10 ), only one imunological disorder ( n= 14 ), combined disorders ( n= 9 ), and no detected abnormality ( n= 64 ). Admission to paediatric ward significantly increased in the group with combined disorders ( P= 0.002 ) compared with the other groups. Also one-third of the babies from this group had a poor neonatal outcome. However, most of the neonatal deaths ( 6/7 = 85.7% ) occurred in the group with no detected abnormality. Conclusion

The prevalence of inherited thrombophilia was considered to be similar between the case and the control groups even when immunological disorders were significantly elevated in pregnancies complicated by the baby being small for gestational age. Combined disorders may represent a potential risk factor for severe small for gestational age infants. However, the aetiology of small for gestational age infants with poor neonatal outcomes remains unknown in most cases.

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1471-0528.2002.00411.x

Affiliations: 1: Department of Obstetrics and Gynaecology, Rouen University Hospital, France 2: Department of Haematology and Coagulation Disorders, Rouen University Hospital, France 3: Department of Obstetrics and Gynaecology, Cochin University Hospital, Paris, France 4: INSERM U519, Rouen University Hospital, France

Publication date: 2002-01-01

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page